VALUE LINE INC 8-K

What Happened
Value Line Inc. filed a Form 8-K (Item 5.02) reporting that long-time director Alfred R. Fiore, who had served since 2010, died on December 6, 2025. On January 16, 2026 the Board appointed Dr. Alexander J. Swistel to serve as a director and as a member of the Board’s Audit Committee. Dr. Swistel is a retired Associate Professor at Weill Cornell Medical College and holds degrees from Harvard University and Brown University School of Medicine.

Key Details

• Alfred R. Fiore, a director since 2010, died December 6, 2025.
• Dr. Alexander J. Swistel was appointed to the Board and the Audit Committee on January 16, 2026.
• Dr. Swistel’s background: retired Associate Professor, Weill Cornell Medical College; Harvard and Brown University School of Medicine alumnus.
• Compensation: Dr. Swistel will receive the same Audit Committee director fee as peers — $40,000 per year. No related-party transactions, no family ties, and no selection arrangements were reported.

Why It Matters
This filing updates investors on a change in board composition and Audit Committee membership following the death of a director. The appointment restores board capacity for oversight of financial reporting and audit matters; the disclosed annual fee is $40,000, a modest corporate expense. The company reported no conflicts of interest or related-party transactions involving the new director.